Sign in
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Thursday, October 15, 2026
Advertising
About Us
Subscribe to Newsletter
Facebook
X
Youtube
Biotech
Medtech
Pharma
Public Health
Real Estate
Events
Home
Search
LATEST ARTICLES
Medtech
Mursla Bio Publishes Study Validating Tissue-Specific Liquid Biopsy Technology
Life Sciences Times
-
October 13, 2026
0
Technology
Quantori Recognized in Everest Group’s 2026 Pharmaceutical R&D IT Services Assessment
Life Sciences Times
-
October 13, 2026
0
Medtech
Insulet Launches Omnipod Discover Diabetes Data Platform Nationwide
Life Sciences Times
-
October 13, 2026
0
People on the Move
Myomo Names Mary-Katherine McClure Chief Commercial Officer
Life Sciences Times
-
October 13, 2026
0
Pharma
Alkermes to Present New Narcolepsy and Sleep Disorder Treatment Data at Sleep Europe 2026
Life Sciences Times
-
October 13, 2026
0
People on the Move
Nimbus Therapeutics Appoints Three Senior Leaders to Advance Drug Discovery Programs
Life Sciences Times
-
October 13, 2026
0
Biotech
Fortitude Biomedicines to Present Preclinical Data on Axial Spondyloarthritis Treatment at ACR Convergence 2026
Life Sciences Times
-
October 13, 2026
0
Medtech
Mauna Kea Technologies Reports 37% Growth in Product Revenue, Extends Financial Runway Through 2027
Life Sciences Times
-
October 9, 2026
0
Biotech
Ginkgo Bioworks to Support $1.5 Billion NSF Research Initiative With Autonomous Laboratory Access
Life Sciences Times
-
October 9, 2026
0
Biotech
Affinia Therapeutics to Present BAG3 Gene Therapy Research and Clinical Trial at 2026 HFSA Meeting
Life Sciences Times
-
October 9, 2026
0
1
2
3
...
921
Page 2 of 921
Most Popular
Verastem Oncology Names Michael Bailey CEO as Daniel Paterson Plans Retirement
October 14, 2026
Zai Lab to Present First Human Trial Data for Experimental Atopic Dermatitis Treatment
October 14, 2026
Takeda Reports Positive Phase 2/3 Results for Experimental Immunodeficiency Treatment
October 14, 2026
Akamis Bio Completes Enrollment in Phase 1b Rectal Cancer Treatment Study
October 14, 2026
Load more
Recent Comments
Recent Comments